500 related articles for article (PubMed ID: 34214449)
1. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis.
Akshintala VS; Sperna Weiland CJ; Bhullar FA; Kamal A; Kanthasamy K; Kuo A; Tomasetti C; Gurakar M; Drenth JPH; Yadav D; Elmunzer BJ; Reddy DN; Goenka MK; Kochhar R; Kalloo AN; Khashab MA; van Geenen EJM; Singh VK
Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):733-742. PubMed ID: 34214449
[TBL] [Abstract][Full Text] [Related]
2. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial.
Sperna Weiland CJ; Smeets XJNM; Kievit W; Verdonk RC; Poen AC; Bhalla A; Venneman NG; Witteman BJM; da Costa DW; van Eijck BC; Schwartz MP; Römkens TEH; Vrolijk JM; Hadithi M; Voorburg AMCJ; Baak LC; Thijs WJ; van Wanrooij RL; Tan ACITL; Seerden TCJ; Keulemans YCA; de Wijkerslooth TR; van de Vrie W; van der Schaar P; van Dijk SM; Hallensleben NDL; Sperna Weiland RL; Timmerhuis HC; Umans DS; van Hooft JE; van Goor H; van Santvoort HC; Besselink MG; Bruno MJ; Fockens P; Drenth JPH; van Geenen EJM;
Lancet Gastroenterol Hepatol; 2021 May; 6(5):350-358. PubMed ID: 33740415
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis and systematic review.
Vadalà di Prampero SF; Faleschini G; Panic N; Bulajic M
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1415-1424. PubMed ID: 27580214
[TBL] [Abstract][Full Text] [Related]
4. Rectal nonsteroidal anti-inflammatory drugs and pancreatic stents in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: A network meta-analysis.
Shou-Xin Y; Shuai H; Fan-Guo K; Xing-Yuan D; Jia-Guo H; Tao P; Lin Q; Yan-Sheng S; Ting-Ting Y; Jing Z; Fang L; Hao-Liang Q; Man L
Medicine (Baltimore); 2020 Oct; 99(42):e22672. PubMed ID: 33080710
[TBL] [Abstract][Full Text] [Related]
5. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with a combination of pharmacological agents based on rectal non-steroidal anti-inflammatory drugs: A systematic review and network meta-analysis.
Oh HC; Kang H; Park TY; Choi GJ; Lehman GA
J Gastroenterol Hepatol; 2021 Jun; 36(6):1403-1413. PubMed ID: 33068012
[TBL] [Abstract][Full Text] [Related]
6. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis.
Akbar A; Abu Dayyeh BK; Baron TH; Wang Z; Altayar O; Murad MH
Clin Gastroenterol Hepatol; 2013 Jul; 11(7):778-83. PubMed ID: 23376320
[TBL] [Abstract][Full Text] [Related]
7. Hydration with Lactated Ringer's solution combined with rectal diclofenac in the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography.
Del Olmo Martínez ML; Velayos Jiménez B; Almaraz-Gómez A
Gastroenterol Hepatol; 2021 Jan; 44(1):20-26. PubMed ID: 32674877
[TBL] [Abstract][Full Text] [Related]
8. Rectal NSAIDs-based combination modalities are superior to single modalities for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a network meta-analysis.
Park TY; Kang H; Choi GJ; Oh HC
Korean J Intern Med; 2022 Mar; 37(2):322-339. PubMed ID: 35168302
[TBL] [Abstract][Full Text] [Related]
9. Network meta-analysis of prophylactic pancreatic stents and non-steroidal anti-inflammatory drugs in the prevention of moderate-to-severe post-ERCP pancreatitis.
Dubravcsik Z; Hritz I; Keczer B; Novák P; Lovász BD; Madácsy L
Pancreatology; 2021 Jun; 21(4):704-713. PubMed ID: 33926821
[TBL] [Abstract][Full Text] [Related]
10. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials.
Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X
Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720
[TBL] [Abstract][Full Text] [Related]
11. Systematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis.
Akshintala VS; Hutfless SM; Colantuoni E; Kim KJ; Khashab MA; Li T; Elmunzer BJ; Puhan MA; Sinha A; Kamal A; Lennon AM; Okolo PI; Palakurthy MK; Kalloo AN; Singh VK
Aliment Pharmacol Ther; 2013 Dec; 38(11-12):1325-37. PubMed ID: 24138390
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of rectal nonsteroidal anti-inflammatory drugs for prophylaxis against post-ERCP pancreatitis: a systematic review and meta-analysis.
Hou YC; Hu Q; Huang J; Fang JY; Xiong H
Sci Rep; 2017 Apr; 7():46650. PubMed ID: 28440297
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Combined Management with Nonsteroidal Anti-inflammatory Drugs for Prevention of Pancreatitis After Endoscopic Retrograde Cholangiography: a Bayesian Network Meta-analysis.
Du F; Zhang Y; Yang X; Zhang L; Yuan W; Fan H; Ren L
J Gastrointest Surg; 2022 Sep; 26(9):1982-1997. PubMed ID: 35680777
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal Anti-inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: a Systematic Review and Meta-analysis.
Liu L; Li C; Huang Y; Jin H
J Gastrointest Surg; 2019 Oct; 23(10):1991-2001. PubMed ID: 30251071
[TBL] [Abstract][Full Text] [Related]
15. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
[TBL] [Abstract][Full Text] [Related]
16. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a cost-effectiveness analysis.
Nicolás-Pérez D; Castilla-Rodríguez I; Gimeno-García AZ; Romero-García R; Núñez-Díaz V; Quintero E
Pancreas; 2015 Mar; 44(2):204-10. PubMed ID: 25406954
[TBL] [Abstract][Full Text] [Related]
17. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
Lyu Y; Cheng Y; Wang B; Xu Y; Du W
BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
[TBL] [Abstract][Full Text] [Related]
18. Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial.
Fogel EL; Lehman GA; Tarnasky P; Cote GA; Schmidt SE; Waljee AK; Higgins PDR; Watkins JL; Sherman S; Kwon RSY; Elta GH; Easler JJ; Pleskow DK; Scheiman JM; El Hajj II; Guda NM; Gromski MA; McHenry L; Arol S; Korsnes S; Suarez AL; Spitzer R; Miller M; Hofbauer M; Elmunzer BJ;
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):132-141. PubMed ID: 31780277
[TBL] [Abstract][Full Text] [Related]
19. Rectal NSAIDs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in unselected patients: Systematic review and meta-analysis.
Shen C; Shi Y; Liang T; Su P
Dig Endosc; 2017 May; 29(3):281-290. PubMed ID: 28112441
[TBL] [Abstract][Full Text] [Related]
20. Rectal Nonsteroidal Anti-Inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: A Network Meta-Analysis.
Yang J; Wang W; Liu C; Zhao Y; Ren M; He S
J Clin Gastroenterol; 2020 Apr; 54(4):305-313. PubMed ID: 32011404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
